Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Sirolimus on Middle Aged Asymptomatic ApoE4 Carriers
NCT07728175Phase 1Recruiting
- Sponsor
- University of Missouri
- Start
- Dec 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) comparing Sirolimus with Placebo (2 arms). Primary endpoint: Change in Cerebral Blood Flow at 4 weeks. Planned start Dec 2026; status: recruiting.
02
Drugs
sirolimus
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07728175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07728175.